LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 101 of 166
Next
>>
>
2501 to 2525 of 4140 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Timepoint	Timepoint Unit	Mean Total Cell Count Before Treatment	Mean Total Cell Count After Treatment	Mean Total Control Cell Count	Mean Relative Cell Count	Mean Normalized Growth Rate Inhibition Value
BT-20	LDN-193189	3.33	uM	LJP5	72	hr	1097	357	3846	0.0923	-0.4691
BT-20	LDN-193189	10	uM	LJP5	72	hr	1097	211	3846	0.0547	-0.6012
BT-20	PF431396	0.04	uM	LJP5	72	hr	1097	3635	3846	0.9462	0.9401
BT-20	PF431396	0.12	uM	LJP5	72	hr	1097	2975	3846	0.7743	0.7352
BT-20	PF431396	0.37	uM	LJP5	72	hr	1097	1739	3846	0.4529	0.2900
BT-20	PF431396	1.11	uM	LJP5	72	hr	1097	1364	3846	0.3553	0.1274
BT-20	PF431396	3.33	uM	LJP5	72	hr	1097	1355	3846	0.3528	0.1240
BT-20	PF431396	10	uM	LJP5	72	hr	1097	780	3846	0.2028	-0.1722
BT-20	Celastrol	0.04	uM	LJP6	72	hr	1097	3972	3673	1.0821	1.0926
BT-20	Celastrol	0.12	uM	LJP6	72	hr	1097	3935	3673	1.0718	1.0811
BT-20	Celastrol	0.37	uM	LJP6	72	hr	1097	3235	3673	0.8812	0.8599
BT-20	Celastrol	1.11	uM	LJP6	72	hr	1097	819	3673	0.2238	-0.1602
BT-20	Celastrol	3.33	uM	LJP6	72	hr	1097	477	3673	0.1300	-0.3802
BT-20	Celastrol	10	uM	LJP6	72	hr	1097	333	3673	0.0907	-0.4958
BT-20	SU11274	0.04	uM	LJP5	72	hr	1097	4164	3846	1.0835	1.0908
BT-20	SU11274	0.12	uM	LJP5	72	hr	1097	3970	3846	1.0326	1.0359
BT-20	SU11274	0.37	uM	LJP5	72	hr	1097	3913	3846	1.0180	1.0202
BT-20	SU11274	1.11	uM	LJP5	72	hr	1097	3539	3846	0.9201	0.9097
BT-20	SU11274	3.33	uM	LJP5	72	hr	1097	3273	3846	0.8521	0.8308
BT-20	SU11274	10	uM	LJP5	72	hr	1097	1251	3846	0.3257	0.0754
BT-20	Canertinib	0.04	uM	LJP6	72	hr	1097	3493	3673	0.9509	0.9428
BT-20	Canertinib	0.12	uM	LJP6	72	hr	1097	3273	3673	0.8912	0.8722
BT-20	Canertinib	0.37	uM	LJP6	72	hr	1097	3100	3673	0.8440	0.8146
BT-20	Canertinib	1.11	uM	LJP6	72	hr	1097	2953	3673	0.8039	0.7643
BT-20	Canertinib	3.33	uM	LJP6	72	hr	1097	2671	3673	0.7274	0.6660

|<
<<
Previous
Page 101 of 166
Next
>>
>
2501 to 2525 of 4140 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)